Life sciences company Element Biosciences sued Illumina on Monday in separate cases in federal courts in California and ...
Enzymes are important tools, and a new technology combining microbiology and AI has exciting potential to advance their use ...
Investing.com -- Tempus AI, Inc. (NASDAQ:TEM) stock rose 5% on Monday after the company announced it received 510 (k) clearance from the U.S. Food and Drug Administration for its RNA-based Tempus xR ...
Tempus AI shares are trading higher Monday morning. The company announced it has received U.S. Food and Drug Administration 510(k) clearance for its RNA-based Tempus xR IVD device.
MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life ...
Partnership delivers advanced reverse transcriptase technology to enhance sensitivity, robustness and reproducibility of ...
The Business Research Company’s Next Generation Tissue Biomarkers Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, September 12, 2025 / ...
Molecular testing helps distinguish kidney cancer subtypes, ensuring patients get accurate diagnoses and treatment plans, ...
Obtaining an accurate diagnosis is a crucial first step in kidney cancer care, according to Dr. Shuanzeng “Sam” Wei of Fox ...
PacBio enters the high-throughput carrier screening market with a standalone HiFi sequencing assay for challenging genes.
3d
Johnson & Johnson's Tecvayli-Darzalex Combo Shows 100% Response In Newly Diagnosed Myeloma Patients
Johnson & Johnson's Tecvayli-Darzalex regimen showed 100% response rates and high MRD negativity in newly diagnosed multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback